Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use Carbinoxamine Maleate Extended-Release Oral Suspension. See full prescribing information for Carbinoxamine Maleate Extended-Release Oral Suspension. Initial U.S. Approval: 1953
Medication labelWhy this: Advisory · dailymed-prescription
Carbinoxamine Maleate extended-release oral suspension is indicated for adults and pediatric patients 2 years of age and older for the symptomatic treatment of: Seasonal and perennial allergic rhinitis Vasomotor rhinitis Allergic conjunctivitis due to inhalant allergens and foods Mild, uncomplicated allergic skin manifestations of urticaria and angioedema Dermatographism As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled Amelioration of the severity of allergic reactions to blood or plasma
- generic_name
- carbinoxamine maleate
- product_names
- Carbinoxamine Maleate
- ndc
- 62542-101, 62542-101-05
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en